Normal Caudate Glucose Metabolism in Persons at Risk for Huntington's Disease
- 1 March 1987
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 44 (3) , 254-257
- https://doi.org/10.1001/archneur.1987.00520150010010
Abstract
• Glucose metabolism was examined by positron emission tomographic scanning with18F-2-fluoro-2-deoxy-d-glucose in 29 persons at risk for Huntington's disease (HD), 28 age-matched controls, nine patients with stage I, and eight patients with stage II symptomatic HD. Absolute caudate metabolic rates and normalized indexes of caudate metabolism for at-risk persons were normal compared with controls. No at-risk person had caudate indexes outside two SDs of the controls' mean. Caudate metabolism in the earliest HD cases was significantly reduced compared with controls and atrisk persons, but within the 99% confidence levels of both groups. Stage II patients had caudate measures that were significantly depressed compared with those of stage I HD patients. Measurement of caudate glucose hypometabolism is unlikely to be sufficiently sensitive to serve as a presymptomatic marker of heterozygote status, although it will provide a sensitive marker for progressive caudate dysfunction in HD.This publication has 7 references indexed in Scilit:
- PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional declineAnnals of Neurology, 1986
- Positron Emission Tomography: Human Brain Function and BiochemistryScience, 1985
- Cerebral Metabolic Rates for Glucose in Mood DisordersArchives of General Psychiatry, 1985
- Cortical abnormalities in Alzheimer's diseaseAnnals of Neurology, 1984
- Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's diseaseJournal of the Neurological Sciences, 1984
- A polymorphic DNA marker genetically linked to Huntington's diseaseNature, 1983
- Huntington diseaseNeurology, 1979